Sales rise 1333.33% to Rs 0.86 crore
Net profit of Shukra Pharmaceuticals remain constant at Rs 0.01 crore in the quarter ended September 2018 and also during the previous quarter ended September 2017. Sales rose 1333.33% to Rs 0.86 crore in the quarter ended September 2018 as against Rs 0.06 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales0.860.06 1333 OPM %31.40100.00 -PBDT0.270.09 200 PBT0.090.01 800 NP0.010.01 0Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
